Biofrontera Inc.
BFRI
$1.08
-$0.02-1.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 504.01% | -17.29% | -1,971.60% | 59.73% | -139.59% |
| Total Depreciation and Amortization | -0.45% | -33.65% | -28.16% | -28.66% | -25.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,656.00% | -33.93% | 102.76% | -105.64% | 100.67% |
| Change in Net Operating Assets | -7,005.56% | -37.82% | 460.23% | -96.07% | 102.06% |
| Cash from Operations | -133.63% | -216.47% | 35.49% | -23.82% | 88.53% |
| Capital Expenditure | 200.00% | -- | -102.08% | 94.74% | -111.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 300,200.00% | -- | 50.00% | -- | -101.37% |
| Total Debt Issued | -- | -- | -- | -- | -65.39% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.98% | 100.00% | 60.86% | -- | -39.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.88% | -153.78% | 870.46% | -266.53% | 245.84% |